Osiris Therapeutics Appoints New Chief Financial Officer and Chief Business Officer
Go back to Osiris Therapeutics Appoints New Chief Financial Officer and Chief Business Officer| Osiris Therapeutics, Inc. (NASDAQ: OSIR) | Delayed: 18.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.99 | 52 Week High | $14.37 | |||
| Open | $25.07 | 52 Week Low | $3.55 | |||
| Day High | $18.99 | P/E | N/A | |||
| Day Low | $18.99 | EPS | $-0.28 | |||
| Volume | 0 | |||||
| Stryker Corp. (NYSE: SYK) | Delayed: 278.34 +0.14 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $278.20 | 52 Week High | $123.55 | |||
| Open | $280.16 | 52 Week Low | $86.68 | |||
| Day High | $281.96 | P/E | 105.83 | |||
| Day Low | $274.45 | EPS | $2.63 | |||
| Volume | 879,279 | |||||



